Fertility preservation in female cancer patients: current developments and future directions

Kim, S. Samuel

doi:10.1016/j.fertnstert.2005.04.071

Cited by 157 publications

(147 citation statements)

References 98 publications

Supporting

Mentioning

135

Contrasting

Unclassified

Order By: Relevance

“…In cases of leukemia or lymphoma, chromosomal and other tumor markers can be studied by immunohistochemical or other molecular biological methods to screen for the presence of cancer cells [112]. In the near future, it may be feasible to screen metastatic cancer cells harbored in the stored tissue before transplantation using immunohistochemistry, flow cytometry, or molecular genetic techniques such as reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization [130].…”

Section: Potential Risks To Patientsmentioning

confidence: 99%

Human oocyte and ovarian tissue cryopreservation and its application

Tao

Valle

2008

J Assist Reprod Genet

View full text Add to dashboard Cite

Purpose To review the recent progress in human oocyte and ovarian tissue cryopreservation, and in the application of these two technologies for preserving female fertility of patients who are undergoing cancer treatment. Design The literature on human oocyte and ovarian tissue freezing was searched with PubMed. The scientific background, current developments and potential future applications of these two methods were reviewed.

show abstract

Section: Potential Risks To Patientsmentioning

confidence: 99%

Human oocyte and ovarian tissue cryopreservation and its application

Tao

Valle

2008

J Assist Reprod Genet

View full text Add to dashboard Cite

show abstract

“…Despite the fact that sperm cryopreservation has been available for decades, deep freezing of oocytes until now has not become a routine procedure [5,14,[19][20]. At the moment, this is far less efficient than the cryopreservation of fertilized eggs.…”

Section: Oocyte Cryopreservationmentioning

confidence: 99%

Procedures for fertility preservation in female cancer patients

Langmár¹,

Iványi²,

Bánhidy³

et al. 2009

Clinical and Experimental Medical Journal

View full text Add to dashboard Cite

n REVIEWS n Modern anticancer drugs and novel oncotherapeutic methods have resulted in increasingly better survival rates and quality of life. However, this therapeutic success has been accompanied by the loss of fertility and premature menopause in many women cured of their disease. Consequently, efforts to preserve reproductive functions are of increasing importance [1][2][3][4][5][6]. The significance of such research is further emphasized by current statistical data showing that approximately one in 700 adults is a survivor of a certain childhood malignant disease. It is estimated that by the year 2010 this proportion will significantly increase and almost one in 250 adults will suffer from the late negative consequences of treatments of childhood cancer, includ-

show abstract

“…[11][12][13][14][15] The choice of the most suitable If the patient has a partner or accepts donor sperm, embryo cryopreservation should be considered first, since this is a clinically well-established procedure. Embryo cryopreservation is the preferred method to preserve fertility due to reasonable delivery rates, according to the Ethics Committee of the American Society for Reproductive Medicine.…”

Section: Strategies To Preserve Fertilitymentioning

confidence: 99%

Fertility preservation for women with malignancies: current developments of cryopreservation

Chang

Suh

2008

J Gynecol Oncol

View full text Add to dashboard Cite

The preservation of fertility in female cancer survivors has become an important health issue. The different cryopreservation options available for fertility preservation are embryo, oocyte, and ovarian tissue cryopreservation. Oocyte cryopreservation is available for women without partners, but there is a limited experience with this technique and the pregnancy rate is still low. In spite of recent reports of successful birth after autotransplantation of cryopreserved-thawed human ovarian cortical tissues, clinical experience is also limited and this technique remains still experimental. Whole ovary cryopreservation itself poses several challenges. Further researches for establishing optimal cryopreservation and thawing protocols and increasing post-thawing survival, pregnancy, and delivery rates are necessary. In this article, the strategies for fertility preservation in cancer survivors are discussed. The different options and their results are discussed, as well as their indications, efficacy and ethical issues.

show abstract

Fertility preservation in female cancer patients: current developments and future directions

Cited by 157 publications

References 98 publications

Human oocyte and ovarian tissue cryopreservation and its application

Human oocyte and ovarian tissue cryopreservation and its application

Procedures for fertility preservation in female cancer patients

Fertility preservation for women with malignancies: current developments of cryopreservation

Contact Info

Product

Resources

About